Endocrine Testing Market

Market Insights

An endocrine system is a group of glands that create and release hormones to control important bodily functions, such as metabolism, growth, reproduction, etc. The endocrine system plays a vital role in the prevention of several chronic and metabolic diseases. Endocrine disorders are classified into two types: diseases caused by the glands overproducing or underproducing hormones (hormone imbalance) and diseases caused by the development of lesions in the endocrine system.

The purpose of this research study titled “Endocrine Testing Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global endocrine testing market. This report presents and analyses the major trends prevalent in the global endocrine testing market and provides market size and forecast.

This report categorizes the global endocrine testing market in terms of test type, endocrine disorder, testing technology, end-users, and geographical distribution.

For the purpose of this study, the test types considered include estradiol (E2) testing, follicle-stimulating hormone (FSH) testing, human chorionic gonadotropin (hCG) hormone testing, luteinizing hormone (LH) testing, dehydroepiandrosterone sulfate (DHEAS) testing, progesterone testing, testosterone testing, stimulating thyroid hormone (TSH) testing, prolactin testing, cortisol testing, insulin testing, and others. The endocrine disorders studied in this report are categorized as adrenal disorders, calcium problems, glucose (islet cell) disorders, male and female gonadal problems, hypertensive and heart disorders, thyroid disorders, and pituitary disorders.

Based on testing technologies, the global endocrine testing market is studied for immunoassay technology, tandem mass spectrometry, sensor technology, monoclonal and polyclonal antibody technology, clinical chemistry technology, and others. This report also categorizes the global endocrine testing market by end-users such as hospitals, clinical laboratories, research and academia, and others. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global endocrine testing market is best understood by segmenting it into five major regions and five major region-level markets, which are as follows:

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• rest of Latin America

Middle East and Africa

• GCC
• Rest of the Middle East and Africa

The market size and forecast of each considered geographical market are presented for the period 2015-2025, along with CAGRs for the forecast period 2017-2025, and further cross-sectional analysis is presented in terms of test type, endocrine disorder, testing technology, end-users, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global endocrine testing market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the endocrine testing market. The key players profiled in this report are Abbott Laboratories, AB Sciex Pte Ltd., Agilent Technologies, Inc., Biomedical Technologies (Alfa Aesar), bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Ortho-clinical Diagnostics, Quest Technology Pte Ltd., Sysmex Corporation, and Teleflex Incorporated.

Based on the types of disorders, the global endocrine testing market is segmented as follows:

• Adrenal Disorders
• Calcium Problems
• Disorders of Glucose (Islet Cells)
• Male and female gonadal problems
• Heart Disorders
• Hypertensive Disorders
• Thyroid Disorders
• Pituitary Disorders

Diabetes is among the most prominent areas where endocrine testing is widely used. As the global prevalence of diabetes rises, experts believe that there is still a large population of undiagnosed patients. People can have prediabetes or type 2 diabetes for several years without exhibiting distinguishable symptoms. As a matter of fact, type 2 diabetes often goes undiagnosed until the related complications appear. Such complications include renal disease, vision impairment, and even nerve damage. If not diagnosed in time and left untreated, diabetes can result in several complications and eventual mortality. Diabetes diagnosis is critical for making the necessary lifestyle changes or taking the necessary medications for disease management. Diabetes screening is frequently advised in people who are at high risk of developing diabetes.

For the purpose of this study, the global endocrine testing market is studied for the following test types:

• Testing for Estradiol (E2)
• FSH (Follicle Stimulating Hormone) Testing
• Human Chorionic Gonadotropin (hCG) Hormone Testing
• Testing for Luteinizing Hormone (LH)
• Testing for Dehydroepiandrosterone Sulfate (DHEAS)
• Progesterone Testing
• Testosterone Testing
• Thyroid-Stimulating Hormone (TSH) Testing
• Prolactin Testing
• Cortisol Testing
• Insulin Testing
• Others

Among the considered test types, thyroid stimulating hormone testing and insulin testing together will capture the largest market share throughout the forecast period of 2017–2025. Thyroid function disorders are common worldwide, and screening and diagnosis form a critical part of disease management. Symptoms of thyroid disorders are extremely prevalent in the general population and are non-specific. Increasing information available to the general public has led to voluntary testing by patients worldwide. TSH, T4, and anti-TPO antibodies are the three most important biochemical tests for assessing thyroid function. The TSH testing assay is the most reliable for detecting primary hypo- and hyperthyroidism, whereas first-generation TSH testing can only detect hypothyroidism.

For the purpose of this study, the global endocrine testing market is segmented as per the following technologies:

• Immunoassay Technology
• Tandem mass spectrometry
• Sensors Technology
• Monoclonal and polyclonal antibody technology
• clinical chemistry technology
• Others

The increasing prevalence of metabolic disorders, sexual dysfunction, diabetes, renal diseases, and obesity has resulted in an increase in demand for endocrine testing methods. Regular monitoring of endocrine hormones plays a critical role in the management of diabetes and related complications across all demographics. There is also an increasing significance of obesity as a co-morbidity in the growing prevalence of disorders of the reproductive system, strokes, cardiovascular diseases, and cancer.

This increase in the patient pool is expected to favor the growth of the endocrine testing market. However, the high costs of novel testing technologies may restrain the widespread acceptance of these tests, especially in developing countries. Among the currently available testing technologies, immunoassay technology is the largest revenue-generating segment, and it is anticipated that the trend will continue during the forecast period. Technologies such as tandem mass spectrometry will witness significant traction through the forecast period as a result of their proven precision and accuracy in result delivery.

Geographically, the global endocrine testing market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

North America (U.S. and Canada) is the clear leader in the global endocrine testing market, followed by Europe. The significant prevalence of obesity, chronic endocrine disorders such as diabetes and thyroid diseases, and reproductive health disorders are the key factors contributing to the dominance of the North American market. Furthermore, supportive government regulations facilitating the swift adoption of novel testing technologies and an evolving reimbursement scenario will additionally drive the North American endocrine testing market. On the other hand, a huge population base and rising incidence of lifestyle-related diseases have led to the emergence of Asia Pacific as the fastest-growing regional market for endocrine testing.

The detailed regional classification of the global endocrine testing market is as follows:

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, and the Rest of Europe)
• Asia Pacific (China, Japan, and the Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East and Africa (GCC plus the rest of the Middle East and Africa)

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Endocrine Testing Market Portraiture
2.2 Global Endocrine Testing Market, by Test Type, 2016 (US$ Mn)
2.3 Global Endocrine Testing Market, by Disorder, 2016 (US$ Mn)
2.4 Global Endocrine Testing Market, by Testing Technology, 2016 (US$ Mn)
2.5 Global Endocrine Testing Market, by End-user, 2016 (US$ Mn)
2.6 Global Endocrine Testing Market Share, by Geography, 2016 Vs 2025 (Value %)

Chapter 3 Global Endocrine Testing Market Analysis
3.1 Market Overview
3.2 Market Drivers
3.2.1.1 Growing Incidence of Hormonal Disorders
3.2.1.2 Advancement in Diagnostic Methods and Assays
3.2.2 Challenges
3.2.2.1 Challenged Adoption in Resource-poor Settings
3.2.3 Opportunities
3.2.3.1 Growing Initiatives towards Facilitating Early Diagnosis
3.3 Attractive Investment Proposition
3.4 Competitive Landscape: Endocrine Testing Market, by Key Players

Chapter 4 Global Endocrine Testing Market, by Test Type
4.1 Overview
4.2 Estradiol (E2) Testing
4.3 Follicle Stimulating Hormone (FSH) Testing
4.4 Human Chorionic Gonadotropin (hCG) Hormone Testing
4.5 Luteinizing Hormone (LH) Testing
4.6 Dehydroepiandrosterone Sulfate (DHEAS) Testing
4.7 Progesterone Testing
4.8 Testosterone Testing
4.9 Thyroid Stimulating Hormone (TSH) Testing
4.10 Prolactin Testing
4.11 Cortisol Testing
4.12 Insulin Testing
4.13 Others

Chapter 5 Global Endocrine Testing Market, by Disorder
5.1 Overview
5.2 Adrenal Disorders
5.3 Calcium-Related Disorders
5.4 Glucose (Islet Cells) Disorders
5.5 Male and Female Gonadal Problems
5.6 Hypertensive & Heart Disorders
5.7 Thyroid Disorders
5.8 Pituitary Disorders

Chapter 6 Global Endocrine Testing Market, by Testing Technology
6.1 Overview
6.2 Immunoassay Technology
6.3 Tandem Mass Spectrometry
6.4 Sensors Technology
6.5 Monoclonal and Polyclonal Antibody Technology
6.6 Clinical Chemistry Technology
6.7 Other Technologies

Chapter 7 Endocrine Testing Market, by End-user
7.1 Introduction
7.2 Hospitals
7.3 Clinical Laboratories
7.4 Research and Academia

Chapter 8 Global Endocrine Testing Market, by Geography, 2015-2025 (US$ Mn)
8.1 Preface
8.2 North America (U.S. and Canada)
8.2.1 North America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.2.2 North America Endocrine Testing Market, by Disorders, 2015 – 2025 (US$ Mn)
8.2.3 North America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.2.4 North America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.2.5 North America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.3 Europe (U.K., Germany, France, Italy, Spain and Rest of Europe)
8.3.1 Europe Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.3.2 Europe Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.3.3 Europe Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.3.4 Europe Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.3.5 Europe Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.4 Asia Pacific (China, Japan, and Rest of APAC)
8.4.1 Asia Pacific Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.4.2 Asia Pacific Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.4.3 Asia Pacific Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.4.4 Asia Pacific Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.4.5 Asia Pacific Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.5 Latin America (Mexico, Brazil and Rest of LATAM)
8.5.1 Latin America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.5.2 Latin America Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.5.3 Latin America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.5.4 Latin America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.5.5 Latin America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
8.6 Middle East and Africa (GCC & Rest of Middle East and Africa)
8.6.1 Middle East and Africa Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
8.6.2 Middle East and Africa Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
8.6.3 Middle East and Africa Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
8.6.4 Middle East and Africa Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
8.6.5 Middle East and Africa Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)

Chapter 9 Company Profiles
9.1 Abbott Laboratories, Inc.
9.2 Agilent Technologies
9.3 bioMerieux S.A.
9.4 Bio-Rad Laboratories, Inc.
9.5 DiaSorin S.p.A.
9.6 F. Hoffmann-La Roche AG
9.7 Ortho Clinical Diagnostics
9.8 SCIEX (Danaher Corporation)
9.9 Siemens AG
9.10 Thermo Fisher Scientific, Inc.

List of Figures

FIG. 1 Endocrine Testing Market: Research Methodology
FIG. 2 Global Endocrine Testing Market, by Test Type, 2016 (US$ Mn)
FIG. 3 Global Endocrine Testing Market, by Disorder, 2016 (US$ Mn)
FIG. 4 Global Endocrine Testing Market, by Testing Technology, 2016 (US$ Mn)
FIG. 5 Global Endocrine Testing Market, by End-user, 2016 (US$ Mn)
FIG. 6 Global Endocrine Testing Market Share, by Geography, 2016 Vs 2025 (Value %)
FIG. 7 Attractive Investment Proposition: Global Endocrine Testing Market, by Geography, 2016
FIG. 8 Competitive Landscape: Endocrine Testing Market, by Key Players, 2016
FIG. 9 Estradiol (E2) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 10 Follicle Stimulating Hormone (FSH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 11 Human Chorionic Gonadotropin (hCG) Hormone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 12 Luteinizing Hormone (LH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 13 Dehydroepiandrosterone Sulfate (DHEAS) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 14 Progesterone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 15 Testosterone Testing Market, 2015 – 2025 (US$ Mn)
FIG. 16 Thyroid Stimulating Hormone (TSH) Testing Market, 2015 – 2025 (US$ Mn)
FIG. 17 Prolactin Testing Market, 2015 – 2025 (US$ Mn)
FIG. 18 Cortisol Testing Market, 2015 – 2025 (US$ Mn)
FIG. 19 Insulin Testing Market, 2015 – 2025 (US$ Mn)
FIG. 20 Others Endocrine Testing Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global Endocrine Testing Market for Adrenal Disorders, 2015 – 2025 (US$ Mn)
FIG. 22 Global Endocrine Testing Market for Calcium Related Disorders, 2015 – 2025 (US$ Mn)
FIG. 23 Global Endocrine Testing Market for Glucose (Islet Cells) Disorders, 2015 – 2025 (US$ Mn)
FIG. 24 Global Endocrine Testing Market for Male and Female Gonadal Problems, 2015 – 2025 (US$ Mn)
FIG. 25 Global Endocrine Testing Market for Hypertensive & Heart Disorders, 2015 – 2025 (US$ Mn)
FIG. 26 Global Endocrine Testing Market for Thyroid Disorders, 2015 – 2025 (US$ Mn)
FIG. 27 Global Endocrine Testing Market for Pituitary Disorders, 2015 – 2025 (US$ Mn)
FIG. 28 Global Endocrine Testing Market for Adrenal Disorders, 2015 – 2025 (US$ Mn)
FIG. 29 Global Endocrine Testing Market for Tandem Mass Spectrometry, 2015 – 2025 (US$ Mn)
FIG. 30 Global Endocrine Testing Market for Sensors Technology, 2015 – 2025 (US$ Mn)
FIG. 31 Global Endocrine Testing Market for Monoclonal and Polyclonal Antibody Technology, 2015 – 2025 (US$ Mn)
FIG. 32 Global Endocrine Testing Market for Clinical Chemistry Technology, 2015 – 2025 (US$ Mn)
FIG. 33 Global Endocrine Testing Market for Other Technologies, 2015 – 2025 (US$ Mn)
FIG. 34 Hospitals Market for Endocrine Testing, 2015 – 2025 (US$ Mn)
FIG. 35 Clinical Laboratories Market for Endocrine Testing, 2015 – 2025 (US$ Mn)
FIG. 36 Research and Academia Market for Endocrine Testing, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 3 Global Endocrine Testing Market, by Testing Technology, 2015 – 2025 (US$ Mn)
TABLE 4 Global Endocrine Testing Market, by End-user, 2015-2025 (US$ Mn)
TABLE 5 Global Endocrine Testing Market, by Geography, 2015 –2025 (US$ Mn)
TABLE 6 North America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 8 North America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 9 North America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 10 North America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 13 Europe Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 15 Europe Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Endocrine Testing Market, By Disorder, 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 19 Asia Pacific Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 20 Asia Pacific Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 23 Latin America Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 24 Latin America Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 25 Latin America Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East and Africa Endocrine Testing Market, by Test Type, 2015 – 2025 (US$ Mn)
TABLE 27 Middle East and Africa Endocrine Testing Market, by Disorder, 2015 – 2025 (US$ Mn)
TABLE 28 Middle East and Africa Endocrine Testing Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 29 Middle East and Africa Endocrine Testing Market, by End-user, 2015 – 2025 (US$ Mn)
TABLE 30 Middle East and Africa Endocrine Testing Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 31 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 32 Agilent Technologies: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 33 bioMerieux S.A.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 34 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 35 DiaSorin S.p.A.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 36 F. Hoffmann-La Roche AG: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 37 Ortho Clinical Diagnostics: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 38 SCIEX (Danaher Corporation): Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 39 Siemens AG: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 40 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)